RAP: RAPAMYCIN IMMUNOSUPPRESSANT DRUG
RAP is a Ligand Of Interest in 2DG9 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 2DG9_RAP_A_501 | 75% | 41% | 0.095 | 0.931 | 1.13 | 1.07 | 4 | 4 | 3 | 0 | 100% | 1 |
| 6M4U_RAP_A_201 | 88% | 35% | 0.067 | 0.948 | 1.83 | 0.7 | 1 | 2 | 0 | 0 | 100% | 1 |
| 6M4W_RAP_D_201 | 79% | 33% | 0.099 | 0.948 | 1.82 | 0.78 | 1 | 3 | 1 | 0 | 100% | 1 |
| 6M4V_RAP_B_201 | 75% | 35% | 0.098 | 0.934 | 1.15 | 1.31 | 5 | 10 | 4 | 0 | 100% | 1 |
| 2DG4_RAP_A_501 | 71% | 42% | 0.104 | 0.927 | 1.1 | 1.03 | 3 | 5 | 0 | 0 | 100% | 1 |
| 2DG3_RAP_A_501 | 59% | 40% | 0.124 | 0.907 | 1.1 | 1.14 | 4 | 6 | 0 | 0 | 100% | 1 |
| 4QT2_RAP_A_202 | 100% | 4% | 0.03 | 0.99 | 2.98 | 2.56 | 11 | 22 | 0 | 0 | 100% | 1 |
| 4DRI_RAP_A_201 | 98% | 41% | 0.046 | 0.974 | 1.05 | 1.13 | 4 | 5 | 0 | 0 | 100% | 1 |
| 1PBK_RAP_A_225 | 97% | 17% | 0.045 | 0.967 | 1.77 | 1.71 | 5 | 16 | 0 | 0 | 100% | 1 |
| 4DRJ_RAP_A_201 | 97% | 38% | 0.049 | 0.969 | 1.23 | 1.08 | 5 | 5 | 2 | 0 | 100% | 1 |
| 4QT3_RAP_A_202 | 96% | 46% | 0.053 | 0.972 | 0.99 | 0.99 | 4 | 4 | 0 | 0 | 100% | 1 |
